NASDAQ$ATYR
aTyr Pharma Inc · Q1 2025 earnings
Q1 2025 earnings ·
Briefing
aTyr Pharma reported Q1 2025, a net loss of $14.9M, diluted EPS of ($0.17).
For Q1 2025, aTyr Pharma reported a net loss of $14.9M, diluted EPS was ($0.17). The filing highlights segment performance, liquidity, and management commentary on the period.
- Net loss $14.9M.
- Diluted EPS ($0.17).
- aTyr Pharma discusses capital allocation and near-term priorities in MD&A.
Headline financials
Revenue & EPS history
aTyr Pharma Inc · Revenue · Quarterly
$0
Forward guidance
Management discusses operating priorities, capital allocation, and sector risks in the quarterly filing.
Tailwinds
- Headline results and segment trends anchor the quarter.
- Liquidity and balance-sheet capacity support operations.
- Strategic initiatives outlined in MD&A.
Headwinds
- Macro, rates, or input costs may pressure margins.
- One-time items affect year-over-year comparability.
- Execution risk on growth or restructuring plans.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 17 quarterly earnings reports · overlaid with Q1 2025
-2.0%
Avg return
Earnings day
+2.0%
Avg return
5 days after
+10.0%
Avg return
30 days after
41%
7 / 17 earnings
Positive
+7.4%
Q2 2020
Best reaction
-8.6%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | -8.6% | +2.2% | -6.1% | |
| Q3 2025 | -5.4% | -3.3% | +1.2% | |
| Q1 2025 | -2.2% | +0.3% | +66.6% | |
| Q3 2024 | -4.6% | +7.4% | +3.4% | |
| Q2 2024 | -3.9% | +5.5% | +3.3% | |
| Q1 2024 | +0.6% | +6.9% | +8.8% | |
| Q3 2023 | -5.7% | -9.0% | -1.6% | |
| Q4 2022 | +1.0% | -3.6% | -1.0% | |
| Q4 2021 | +0.0% | +6.5% | +4.2% | |
| Q3 2021 | +1.2% | -1.7% | -7.0% | |
| Q2 2021 | +0.8% | -2.3% | +14.2% | |
| Q1 2021 | +1.7% | +11.6% | +31.2% | |
| Q3 2020 | +0.6% | -1.8% | +38.1% | |
| Q2 2020 | +7.4% | +20.6% | -1.4% | |
| Q1 2020 | -5.4% | -6.1% | -15.9% | |
| Q3 2019 | -6.2% | -3.9% | +7.2% | |
| Q2 2019 | -5.7% | +4.7% | +24.9% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro